Dr. Hangyi Yan

Biography

• Division:Division of Basic and Integrative Biological Sciences – DTCS
• Review Branch:Respiratory, Cardiac, and Circulatory Sciences – RCCS
• Study Section:Small Business: Respiratory Sciences – RCCS (11)

Dr. Yan received her Ph.D. in biology from Johns Hopkins University. Her dissertation research at the National Cancer Institute (NCI) focused on immuno-oncology to understand how host immunity affects metastasis. For her post-doctoral training at the Food and Drug Administration (FDA), Dr. Yan established humanized mouse models to predict immunotoxicity of biologics. Prior to joining CSR, Dr. Yan was a policy analyst with a focus on device determination and device classification at the Center for Devices and Radiological Health (CDRH), FDA. She also served as a scientific reviewer for hematology in vitro diagnostic medical devices at CDRH/FDA.